Good response to the late treatment with ataluren in a boy with Duchenne muscular dystrophy: could the previous mild course of the disease have affected the outcome?

Duchenne muscular dystrophy (DMD) is a severe, progressive X-linked recessive disorder, caused by the absence of the dystrophin protein. A resolutive therapy for DMD is not yet available. The first approved drug for DMD patients with nonsense mutations is ataluren, approved for the treatment of chil...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasca, Ludovica, Gardani, Alice, Paoletti, Matteo, Velardo, Daniele, Berardinelli, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore Srl 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628801/
https://www.ncbi.nlm.nih.gov/pubmed/36349184
http://dx.doi.org/10.36185/2532-1900-078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628801/
https://www.ncbi.nlm.nih.gov/pubmed/36349184
http://dx.doi.org/10.36185/2532-1900-078

Ejemplares similares